$HSGX Ocugen, Inc. Insider Trading Week 40/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocugen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ocugen, Inc. in week 40/2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 111,111 | 250,000 | 177,777 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 33,333 | 74,999 | 66,666 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 2.25 | 33,333 | 74,999 | 33,333 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 200 | 0 | 320 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 60 | 0 | 120 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Option Exercise | A | 0.00 | 60 | 0 | 60 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 22,113 | 49,754 | 85,800 | 63.7 K to 85.8 K (+34.72 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 6,634 | 14,927 | 63,687 | 57.1 K to 63.7 K (+11.63 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | RAKIN KEVIN | Director | Grant | A | 2.25 | 6,634 | 14,927 | 57,053 | 50.4 K to 57.1 K (+13.16 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | A | 2.25 | 1,244,444 | 2,799,999 | 0 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Option Exercise | A | 0.00 | 2,243 | 0 | 0 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Wilmslow Estates Ltd | 10% Owner | Grant | A | 2.25 | 247,665 | 557,246 | 2,075,331 | 1.8 M to 2.1 M (+13.55 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 2.25 | 1,244,444 | 2,799,999 | 0 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Option Exercise | A | 0.00 | 2,243 | 0 | 0 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | Lewis Michael | Director | Grant | A | 2.25 | 247,665 | 557,246 | 2,075,331 | 1.8 M to 2.1 M (+13.55 %) |
Oct 03 2016 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Option Exercise | P | 2.25 | 1,390,844 | 3,129,399 | 1,390,844 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Option Exercise | P | 0.00 | 2,507 | 0 | 2,507 | |
Oct 03 2016 | HSGX | HISTOGENICS CORP | SPLIT ROCK PARTNERS II, LP | 10% Owner | Buy | P | 2.25 | 276,801 | 622,802 | 1,661,495 | 1.4 M to 1.7 M (+19.99 %) |